These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19540730)

  • 21. Sex- and Subtype-Related Differences in the Comorbidity of Adult ADHDs.
    Groß-Lesch S; Dempfle A; Reichert S; Jans T; Geissler J; Kittel-Schneider S; Nguyen TT; Reif A; Lesch KP; Jacob CP
    J Atten Disord; 2016 Oct; 20(10):855-66. PubMed ID: 24196345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance dependence and eating disorders: impact of sequence on comorbidity.
    Wiseman CV; Sunday SR; Halligan P; Korn S; Brown C; Halmi KA
    Compr Psychiatry; 1999; 40(5):332-6. PubMed ID: 10509613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is caffeine addictive? The most widely used psychoactive substance in the world affects same parts of the brain as cocaine].
    Daly JW; Holmén J; Fredholm BB
    Lakartidningen; 1998 Dec; 95(51-52):5878-83. PubMed ID: 9889511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caffeine consumption in hospitalized psychiatric patients.
    Rihs M; Muller C; Baumann P
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(2):83-92. PubMed ID: 9063913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical comorbidity in elderly psychiatric inpatients.
    Zubenko GS; Marino LJ; Sweet RA; Rifai AH; Mulsant BH; Pasternak RE
    Biol Psychiatry; 1997 Mar; 41(6):724-36. PubMed ID: 9066997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Commonly used stimulants: Sleep problems, dependence and psychological distress.
    Ogeil RP; Phillips JG
    Drug Alcohol Depend; 2015 Aug; 153():145-51. PubMed ID: 26049205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The frequency of caffeine withdrawal in a population-based survey and in a controlled, blinded pilot experiment.
    Dews PB; Curtis GL; Hanford KJ; O'Brien CP
    J Clin Pharmacol; 1999 Dec; 39(12):1221-32. PubMed ID: 10586387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychiatric comorbidity and severity of dependence on substance users: how it impacts on their health-related quality of life?
    Lozano ÓM; Rojas AJ; Fernández Calderón F
    J Ment Health; 2017 Apr; 26(2):119-126. PubMed ID: 27128492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychiatric comorbidity, psychological distress, and quality of life in gamma-hydroxybutyrate-dependent patients.
    Kamal RM; Dijkstra BA; de Weert-van Oene GH; van Duren JA; de Jong CA
    J Addict Dis; 2017; 36(1):72-79. PubMed ID: 27449738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caffeine withdrawal: a parametric analysis of caffeine dosing conditions.
    Evans SM; Griffiths RR
    J Pharmacol Exp Ther; 1999 Apr; 289(1):285-94. PubMed ID: 10087016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychiatric features of 36 men convicted of sexual offenses.
    McElroy SL; Soutullo CA; Taylor P; Nelson EB; Beckman DA; Brusman LA; Ombaba JM; Strakowski SM; Keck PE
    J Clin Psychiatry; 1999 Jun; 60(6):414-20; quiz 421-2. PubMed ID: 10401925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
    Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
    Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeine, sleep and wakefulness: implications of new understanding about withdrawal reversal.
    James JE; Keane MA
    Hum Psychopharmacol; 2007 Dec; 22(8):549-58. PubMed ID: 17868185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substance use disorders in individuals with body dysmorphic disorder.
    Grant JE; Menard W; Pagano ME; Fay C; Phillips KA
    J Clin Psychiatry; 2005 Mar; 66(3):309-16; quiz 404-5. PubMed ID: 15766296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caffeine reinforcement: the role of withdrawal.
    Schuh KJ; Griffiths RR
    Psychopharmacology (Berl); 1997 Apr; 130(4):320-6. PubMed ID: 9160847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance abuse, temperament and suicide risk: evidence from a case-control study.
    Pompili M; Innamorati M; Lester D; Akiskal HS; Rihmer Z; del Casale A; Amore M; Girardi P; Tatarelli R
    J Addict Dis; 2009; 28(1):13-20. PubMed ID: 19197591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
    Kalechstein AD; Newton TF; Longshore D; Anglin MD; van Gorp WG; Gawin FH
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):480-4. PubMed ID: 11083165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caffeine dependence syndrome. Evidence from case histories and experimental evaluations.
    Strain EC; Mumford GK; Silverman K; Griffiths RR
    JAMA; 1994 Oct; 272(13):1043-8. PubMed ID: 8089887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of associated features and drug treatment between co-occurring unipolar and bipolar disorders in depressed eating disorder patients.
    Tseng MM; Chang CH; Liao SC; Chen HC
    BMC Psychiatry; 2017 Feb; 17(1):81. PubMed ID: 28241886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Links between eating disorder symptom severity and psychiatric comorbidity.
    Spindler A; Milos G
    Eat Behav; 2007 Aug; 8(3):364-73. PubMed ID: 17606234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.